Abstract. Injury to neonatal nerves, unlike adult nerves, results in poor regeneration and extensive motoneuron death. We examined whether exposure to a more mature nerve environment could rescue axotomized motoneurons following neonatal injury. The sciatic nerve in 1 hindlimb of 3-day-old (P3) rats was transected and the cut end sutured to a nerve graft taken from donor rats, which ranged between P3 and P21. The extent of motoneuron survival and axon regeneration was established 7 days later. Since integrins play an important role in regeneration, we also examined the effect of manipulating integrin binding in nerve grafts. Following axotomy at P3 and implantation of nerve grafts from 3-day-old rats, approximately 38% of motoneurons survived. In contrast, grafts from rats aged 5 days and older resulted in an improvement in regeneration, and over 70% of motoneurons survived. This survival-promoting effect of P5 grafts was prevented by blocking ␤ 1 -integrins. In contrast, increasing ␤ 1 -integrin levels in grafts from P3 rats dramatically increased motoneuron survival. Thus, following neonatal nerve injury, exposure to a more mature nerve environment significantly increases motoneuron survival, an effect that is dependent upon ␤ 1 -integrin signaling. Therefore, pharmacological upregulation of ␤ 1 -integrins may significantly improve the outcome of neonatal nerve injuries.
INTRODUCTION
It is well established that motoneurons of adult rats are able to survive following injury to the peripheral nerve, although the same insult in newborn rats results in the death of a large proportion of motoneurons (1) (2) (3) . Many of these motoneurons die rapidly after injury by a process of apoptosis (4, 5) . This death of target-deprived motoneurons is likely to be a result of the loss of functional contact between the motor nerve terminal and muscle fiber or the terminal Schwann cell (6) . However, the dependence of motoneurons on contact with their target declines rapidly during the first postnatal week so that nerve injury in animals at 5 days of age results in little or no motoneuron death (7, 8) . Following neonatal nerve injury, Schwann cells have been shown to play an important role in guiding and promoting the survival of regenerating axon terminals (9) . It is therefore possible that the extremely rapid death of motoneurons that follows nerve injury in immature animals is, at least in part, due to the inability of Schwann cells in the distal stump of the injured neonatal nerve to interact with the growth cone of the regenerating motor axons.
Such a possibility is supported by results of experiments in which embryonic motoneurons were transplanted into an adult spinal cord and connected to either a neonatal or adult nerve-muscle conduit (10) . Following connection to an adult nerve-muscle graft, many transplanted neurons survived and their axons entered the peripheral nerve implant. In contrast, hardly any grafted motoneurons survived when a neonatal nerve-muscle implant was used (10) . These results suggest that the growth cones of regenerating axons were unable to interact with the environment of the immature nerve grafts.
It appears, therefore, that there is a marked difference in the ability of mature and immature nerves to support axon regeneration and motoneuron survival. Uninjured immature nerves are known to undergo many changes during the first few days of postnatal development. For example, Schwann cells develop into either myelinating or nonmyelinating cells. This process of Schwann cell differentiation is thought to be driven by signaling from the axons and can be reversed if Schwann cells lose contact with the axon, for example, following axotomy (11) . The ability of injured immature and mature nerves to support axon regeneration and motoneuron survival may be related to these changes.
In this study, we compared the ability of nerve grafts from rats of different developmental stages to influence the survival of axotomized motoneurons. The sciatic nerve of 3-day-old (P3) rats was axotomized and the proximal stump of the injured nerve was connected to a peripheral nerve graft taken from either an adult or a developing animal. The results show that there was a significant increase in the survival of injured motoneurons when a nerve graft from donor rats aged 5 days and older was implanted onto the cut end of the neonatal nerve, although grafts from P3 rats had no effect on motoneuron survival. Therefore, in the second part of this study we examined the possible reasons for the improvement in motoneuron survival observed in those animals that received a more mature nerve graft.
Following axotomy, growth cones enter the peripheral nerve stump where they interact with their immediate environment via receptors on the terminal filopodia. These receptors are capable of recognizing a variety of diffusible and extracellular matrix (ECM)-bound environmental signals. Integrins, one of the major ECM receptors on axons and Schwann cells, are heterodimeric transmembrane receptors that link the extracellular environment with the actin cytoskeleton in cells. Integrins are known to be important for axonal growth, both in the central and peripheral nervous systems (12) (13) (14) (15) . Furthermore, there is an important difference between mature and immature axotomized nerves in that there is an upregulation of the laminin/collagen receptor ␣1␤1 integrin in Schwann cells isolated from axotomized adult, but not neonatal nerves (16) . Subunits of laminin-associated integrins are differentially expressed in adult and postnatal rat motoneurons (17) , and following nerve section in the adult, mRNA for these integrin subunits is profoundly upregulated, although the same injury in neonates results in only minor changes in mRNA levels (17) . In addition, recent work by Condic (18) has shown that in cultured DRG neurons there is a clear intrinsic difference in the regenerative capacity of mature and immature neurons, which is related to the low level of integrin expression in adult neurons compared to postnatal neurons. Their findings also show that upregulating integrin expression in adult DRGs increases their regenerative capacity to that observed in immature neurons. Moreover, we have previously shown that blocking ␤1 integrins at the neuromuscular junction of neonatal rats results in the death of otherwise healthy motoneurons (19) . Therefore, in this study we examined the expression of integrins in developing and mature nerves, and tested whether they played a role in the regeneration and survival of motoneurons following neonatal nerve injury.
MATERIALS AND METHODS

Surgical Procedures
All experiments were performed on inbred Sprague-Dawley rats of both sexes (Biological Services, University College, London, UK and Albert Szent-Gyorgyi Medical University, Hungary). Every effort was made to minimize animal suffering. The experiments were carried out under license from the Home Office in accordance to the Animals (Scientific Procedures) Act 1986 and overseen by the Ethical Committee of the Institute of Neurology.
Motoneurons innervating the tibialis anterior (TA) muscles in both hindlimbs of P1 ''host'' rats were prelabeled by injecting the muscles with the fluorescent retrograde neuronal markers Fast Blue and Diamidino Yellow (FB/DiY), 0.5-1.0 l, 2% solution (EMS-Chemie GmbH, Warthweg, Germany) under halothane anesthesia. Two days later, the P3 pups were reanesthetized and the right sciatic nerve was exposed in the mid-thigh region and transected approximately 5 mm proximal to division into the tibial and common peroneal nerves. In one group, the sciatic nerve was permanently axotomized proximal to the branches innervating the soleus and gastrocnemius muscles by removing a 5-mm-long nerve segment. The ends of the nerve were then tied off with sutures and the proximal nerve stump sutured to the adjacent innervated musculature in the thigh (quadriceps) in order to prevent the nerve reapproximating with the distal nerve stump. This prevented the possibility of reinnervation of hindlimb muscles. In other experimental groups, the axotomized ''host'' animals received nerve grafts from donor syngeneic rats ranging from 3 to 21 days of age. Nerve segments, approximately 4 to 5 mm in length, of the distal sciatic nerve (P3 and P5 rats) or the common peroneal nerve (P10, P15, and P21) of donor rats were removed and sutured to the cut proximal and distal ends of the host sciatic nerve using fine nylon thread (Ethicon 10/0; Ethicon Ltd., Bracknell, UK). In all cases, graft material was maintained in oxygenated Hank's balanced salt solution (Sigma Aldrich Co. Ltd., Poole, UK) prior to transplantation. Following recovery from the anesthetic, the ''host'' rats were returned to their mothers.
Motoneuron Survival
Motoneuron survival was assessed 3 and 7 days after grafting. The animals were deeply anesthetized with 100 to 200 mg pentobarbital, i.p. (WNJ Dunlop Ltd., Dumfries, UK) and perfused transcardially with a fixative containing paraformaldehyde in 1% in phosphate buffered solution (PBS) (VWR International, Lutterworth, UK). The spinal cords were removed and postfixed for 4 h in the same fixative and cryoprotected overnight in sucrose (30% in PBS). Spinal cord sections were serially sectioned at 30 m on a cryostat. The sections were examined for fluorescence under ultraviolet illumination (395-425 nm excitation wavelength). In animals where motoneuron survival was assessed 7 days after surgery, the number of fluorescently prelabeled motoneurons in both the control and operated ventral horns was counted. An example of a spinal cord in which motoneurons innervating the TA muscles in the operated and contralateral control hindlimb were retrogradely labeled is shown in Figure 1 . In addition, the survival of motoneurons within the sciatic motor pool was also assessed 3 and 7 days after grafting by counting the number of Nissl-stained motoneurons within the sciatic motor pool of each ventral horn. Spinal cord sections were stained with gallocyanin (Sigma Aldrich Company Ltd.), a Nissl stain, and the motoneurons in the ventral horn on both sides of every third section were counted. Only large polygonal neurons with distinguishable nuclei and nucleoli were included in the counts. All counts were performed ''blind'' by 3 of the authors and each spinal cord was counted at least 3 times. The exact size of the segment of the spinal cord that was removed varied slightly between individual animals, leading to some variation in the precise number of sections assessed in each case. Therefore, as an index of motoneuron survival, in each animal the number of labeled cells on the Fig. 1 . A: The photomicrograph shows an example of a spinal cord from a rat in which the sciatic nerve was axotomized at P3 and sutured to a nerve graft from a 3-day-old donor rat. The motoneurons innervating the TA muscles in both the operated and control hindlimbs were retrogradely prelabeled with FB/DiY. The control dorsal horn was premarked with a fine micropin for identification (arrow). It can be seen that 7 days after axotomy and implantation of a P3 nerve graft, there are fewer fluorescent motoneurons present in the operated ventral horn compared to the control ventral horn. B: A high-power image of the operated ventral horn. The FB/DiY-labeled motoneurons are surrounded by smaller, spindle-shaped cells (arrowheads). It is likely that these are microglia that have phagocytosed the dying motoneurons and thus taken up the fluorescent label. C: A high-power image of the control ventral horn. It can be seen that FB labels the cytoplasm of the motoneuron while DiY labels the nucleus. Scale bar ϭ 100 m. 
Manipulation of Integrin Binding
Integrin function in the peripheral nerve grafts was manipulated either by blocking integrin binding or upregulating its expression. Integrin binding was blocked in vivo by treatment with the cyclic peptide FR-1 (Novabiochem, CN Biosciences Ltd., Beeston, UK). In addition, integrin binding was also blocked with a function-blocking antibody directed against the ␤1 integrin subunit (Becton Dickinson Ltd., Cowley, UK), which we have previously used to block ␤1 binding in vivo (19) . In this case, the nerve grafts were first treated with the antibody in vitro immediately prior to grafting, as well as in vivo following implantation of the nerve graft into the host animal. Integrin expression was increased by treating nerve grafts with phorbol 12-myristate 13-acetate (PMA) (Sigma Aldrich Co. Ltd.). PMA has previously been shown to increase ␤ 1 integrin expression in Schwann cells in vitro (16) .
Treatment with FR-1 and PMA Silicon Implants: Motoneurons innervating the TA muscle were prelabeled at P1 as described above. When the rats were 3 days old, the right sciatic nerve was cut. These rats then received a nerve graft from a 3-day, 5-day, or 21-day ''donor'' rat. The nerve grafts were surrounded with silicone rubber implants (Dow Corning, 3140 RTV; VWR International) containing either FR-1 or PMA. (A detailed description of the preparation and use of such silicone implants has been published [20] ). In brief, the active compound (PMA or FR-1) was thoroughly mixed with silicone rubber solution. The mixture was left to dry before being cut into small strips. Implants weighing up to 0.5 mg were inserted in each experimental rat. Each silicone strip contained either 0.03 mg PMA or 20 ng FR-1. Silicone implants containing sodium chloride were used as controls. We have previously shown that this method of drug delivery results in the release of compounds from the silicon implants over a period of 2 to 3 days (20) .
Treatment with a ␤1 Function-Blocking Antibody: Integrin binding was also blocked by treating nerve grafts with a function-blocking monoclonal antibody specifically directed against the ␤1 integrin subunit (monoclonal hamster anti-rat CD29; Becton Dickinson Ltd.). Nerve grafts that had been removed from P5 donor rats were preincubated in vitro for 15 to 20 min in the antibody solution (0.5 mg/ml) prior to grafting. Once the graft had been sutured into place, in order to prolong the effect of the antibody the nerve grafts were then surrounded with sterile gelatine sponge pledgets (Spongostan Standard, Ferrosan; Johnson and Johnson, Skipton, UK) that had been presoaked in 5 l antibody solution (2.5 g antibody). The wound was then closed. Control nerve grafts were treated as above with 0.9% sterile saline.
Histochemistry and Immunohistochemistry
Following transcardiac perfusion with paraformaldehyde, 1% in PBS (Sigma Aldrich Co. Ltd), the sciatic nerve, including the graft and proximal and distal ends of the host sciatic, was removed, postfixed in the same fixative, and cryoprotected in 30% sucrose (VWR International). The nerve grafts were longitudinally sectioned at 12 m on a cryostat. In order to assess possible graft rejection, lymphocytic infiltration of the grafts was revealed by staining some sections with hematoxylin and eosin (H&E; Sigma Aldrich Co. Ltd.). The remaining nerve sections were immunostained for the following markers: a) ␤ 1 integrin subunit (1:250 hamster anti-rat CD29; Becton Dickinson Ltd.); b) neurofilament light chain (NF68-1:200 mouse monoclonal; Sigma Aldrich Co. Ltd.); and c) Schwann cells (S100-1:200 rabbit anti-cow; Dako Ltd., High Wycombe, UK). The sections were washed in PBS with 0.1% Triton-X (PBS-T) and incubated for 1 h with 3% normal goat serum and 5% nonfat milk (␤1 integrin and S100), or 3% normal horse serum and 5% nonfat milk (neurofilament-68). The sections were then incubated overnight at 4ЊC with the primary antibody. Negative controls (where the primary antibody was omitted) were also prepared. The following day, the sections were washed in PBS-T (PBS with 0.01% Triton-X-100; Sigma Aldrich Co. Ltd.) and incubated for 2 h at room temperature with the appropriate secondary antibody (for ␤1 integrin in goat anti-hamster 1:100; for NF68 in horse anti-mouse 1:100; for S100 in goat anti-rabbit 1:100; Vector Laboratories Ltd., Peterborough, UK). The sections were then incubated in an avidin-biotin complex (ABC solution; Vector Laboratories Ltd.) for 1 h and then activated diaminobenzidine (SigmaFast DAB; Sigma Aldrich Co. Ltd.). The sections were then dehydrated, mounted, and examined under a light microscope.
In some cases, nerve sections were processed for double immunofluorescence for S100 and ␤ 1 . In this case the sections were first stained for ␤1 integrins (1:250 hamster anti-mouse CD29, Pharmingen; 1:100 fluorescein conjugated goat antihamster secondary antibody; Vector Laboratories Ltd.) and then processed for S100 proteins (1:400 rabbit anti-cow, Dako; 1: 100 biotinylated goat anti-rabbit secondary antibody, Vector; 1: 100 Texas Red Avidin; Vector Laboratories Ltd.). The sections were then examined under a fluorescent microscope using filters of the appropriate wavelength. The presence of Schwann cells was also determined morphologically after staining the sections with H&E and Hoechst 33245 (1:1,000; Sigma Aldrich Co. Ltd.), which binds specifically to DNA.
Statistical Analysis
The results of these experiments were analyzed using the Mann-Whitney U-test for comparison of independent samples. Two-tailed tests were used in all instances and the significance was set as p Ͻ 0.05.
RESULTS
Following axotomy at P3 and implantation of nerve grafts, the effect on motoneuron survival and axon regeneration was examined 7 days later. In order to assess whether there was any rejection of the nerve grafts, sections of the grafts from donor rats of each age were examined for lymphocytic infiltration by staining with H&E. We observed no evidence of rejection of any nerve graft and there was no significant lymphocytic infiltration of any graft.
Motoneuron Survival after Neonatal Axotomy Can Be Influenced by Peripheral Nerve Grafts
The Effect of Neonatal (P3) and Mature (P21) Nerve Grafts: Following axotomy at P3 and implantation of nerve grafts from P3 or P21 donor rats, motoneuron survival was assessed 7 days later by counting the number of motoneurons prelabeled with the fluorescent retrograde tracers FB/DiY, as well as the numbers of Nissl-stained motoneurons within the sciatic motor pool in the operated and control ventral horns. An example of spinal cord of a rat that was axotomized at P3 and which received a nerve graft from a 3-day-old donor is shown in Figure 1 . Following axotomy at 3 days, host rats were implanted with nerve grafts from either 3-or 21-day-old donor rats. One group received no nerve graft. The survival of motoneurons innervating the TA muscle was assessed by counting the number of motoneurons that had been prelabeled by injecting the TA muscle with FB/DiY.
In addition, the number of Nissl-stained motoneurons within the sciatic motor pool in the operated (Op) and control (Con) ventral horns of each spinal cord was counted. The table shows the mean number of motoneurons on each side and as an index of motoneuron survival. The number of motoneurons on the operated side is also expressed as a percentage of that on the control side. SEM ϭ standard error of the mean.
Fig. 2.
Motoneuron survival 7 days after axotomy at 3 days and grafting of nerve segments from donor rats aged between 3 and 21 days. Motoneuron survival was established by counting the number of Nissl-stained motoneurons within the sciatic motor pool in the Operated (Op) and Control (Con) ventral horn. As an index of motoneuron survival, the number of motoneurons on the operated side is expressed as a percentage of the number on the control side. There is no difference in motoneuron survival in the group that received a nerve graft from a 3-day-old donor compared to the group in which the nerve was axotomized and no graft was given (p ϭ 0.723). However, in the group that received nerve grafts from donor rats aged 5 days, there was a significant increase in motoneuron survival (p ϭ 0.001). However, there was no further increase in motoneuron survival observed in animals that received grafts from donors aged 10, 15, or 21 days (p Ͼ 0.05). Error bars are standard error of the mean (SEM).
It can be seen that there are significantly fewer FB/DiYlabeled motoneurons in the operated ventral horn compared to the control ventral horn. The results summarized in Table 1 and Figure 2 show that there is no significant difference in motoneuron survival in the group that received a P3 graft compared to the group in which the sciatic nerve was axotomized and no graft implanted (p ϭ 0.723). However, in the group that received a nerve graft from a 21-day-old donor there was a significant increase in motoneuron survival (p Ͻ 0.001).
These results show that neonatal nerve grafts are unable to enhance motoneuron survival after axotomy, whereas grafts from adult animals are able to rescue immature motoneurons from axotomy-induced cell death. We next established the developmental stage at which nerve grafts acquire the ability to rescue injured motoneurons.
The Effect of Donor Age on Motoneuron Survival: Following implantation of nerve grafts from donor rats aged 5, 10, or 15 days of age, motoneuron survival was assessed 7 days later (Fig. 2) . Unlike nerve grafts from P3 rats, those from P5 animals were able to dramatically improve motoneuron survival. This effect of nerve grafts from animals at P5 was comparable to that observed with grafts P21 animals. Thus, in the group that received a P3 graft, only 38.3% (Ϯ1.0 SEM, n ϭ 7) of motoneurons The extent of axon regeneration as determined by neurofilament immunostaining was assessed 3 and 7 days after grafting. Three days after grafting there was no evidence of axon growth through any grafts, irrespective of donor age (A-C). By 7 days after grafting, in those rats that received a graft from a 3-day-old donor rat (D), very few axons were detected in the graft and these extended only a short way into the graft. In contrast, numerous axons could be seen extending through P5 (E) and P21 (F) grafts. The arrows denote the proximal and distal graft anastomoses. Scale bar ϭ 1 mm.
survive following axotomy at P3, compared to 71.4% (Ϯ3.2 SEM, n ϭ 9) in the group that received a P5 nerve graft. This increase in motoneuron survival is highly significant (p ϭ 0.001), and is similar to that observed in animals that received grafts from older animals aged 10, 15, or 21 days (Fig. 2) .
Thus, nerve grafts from animals aged 5 days and older can rescue a large proportion of axotomized motoneurons. Nevertheless, a proportion of the injured motoneurons still dies. This loss of motoneurons may be due to the fact that these motoneurons may die almost immediately after injury, even before they extend axons into the nerve grafts. Therefore, we established the extent of motoneuron death that occurs during the early period after nerve injury and grafting. Longitudinal nerve sections immunostained for neurofilaments showed that 3 days after grafting, few if any axons had grown into the nerve grafts, irrespective of the age of the donor animal (Fig.  3) . The extent of motoneuron death that occurs in each group at this stage is summarized in Table 2 . It can be seen that 3 days after grafting there was no significant difference in motoneuron survival in rats receiving P3, P5, or P21 nerve grafts, and an average of 84.9% (Ϯ2.6 SEM, n ϭ 12) of motoneurons survived. Thus, approximately 15% of motoneurons within the sciatic motor pool die within the first 3 days after axotomy at P3, before their axons are able to reach the nerve graft.
In rats that received a P3 nerve graft, the number of surviving motoneurons continued to decline between 3 and 7 days after surgery, when survival fell from 85.6% (Ϯ1.8 SEM, n ϭ 5) at 3 days to 38.3% (Ϯ1.0 SEM, n ϭ 7) at 7 days (compare Tables 1 and 2 ). In contrast, in the group that received a P5 nerve graft, significantly more motoneurons survive and 71.4% (Ϯ3.2 SEM, n ϭ 9) of motoneurons were still present 7 days after grafting Thus, following axotomy at P3, approximately 15% of sciatic motoneurons die within the first 3 days of injury, irrespective of the age of the donor rat from which the graft was taken. However, 4 days after their axons contact and grow into the nerve grafts, implantation of a P5 nerve graft prevents motoneuron death, so that significantly more motoneurons survive in animals that receive a P5 nerve graft compared to those that receive a P3 nerve graft.
Axon Regeneration through Nerve Grafts: Whether the ability of nerve grafts from rats aged 5 days and older to Following axotomy at 3 days, nerve grafts from 3-, 5-, or 21-day-old donor rats were implanted into the cut end of the host nerve. Motoneuron survival was examined 3 days later by counting the number of Nissl-stained motoneurons within the sciatic motor pool in the operated (Op) and control (Con) ventral horns. The table shows the mean number of motoneurons on each side and as an index of motoneuron survival. The number of motoneurons on the operated side is also expressed as a percentage of the control. SEM ϭ standard error of the mean.
rescue axotomized motoneurons was related to the ability of these grafts to support axonal regeneration was investigated next. The extent of axon growth was established in nerve grafts taken from animals aged 3, 5, 10, 15, and 21 days and connected to the cut end of the sciatic nerve in 3-day-old animals. Examples of the pattern of neurofilament staining observed in grafts taken from 3-, 5-, and 21-day-old animals are shown in Figure 3 . The pattern of neurofilament staining observed 3 days after grafting is very similar for each experimental group. Neurofilament-stained axons can be seen at the proximal host graft interface irrespective of the age of the nerve graft (Fig.  3A-C) . However, 7 days after grafting there is a dramatic difference in the extent of neurofilament staining of axons in the grafts taken from animals of different ages. In animals receiving grafts from 3-day-old animals, very few neurofilament-stained axons were present in the graft (Fig. 3D) . Furthermore, no axons had emerged from the distal end of the graft to penetrate the distal host nerve. In contrast, significant axon growth had occurred in the nerve grafts taken from 5-and 21-day-old animals ( Fig.  3E, F) . Axons could also be found leaving the graft and penetrating the distal segment of the host nerve, although at this stage there was no evidence of axons extending more than 5 mm into the distal host stump or contacting muscle.
The Expression of Schwann Cells and ␤ 1 Integrins in Nerve Grafts from Donor Rats of Different Ages
Schwann cells and ECM receptors, such as integrins, play an important role in nerve regeneration. We therefore examined the expression of the Schwann cell marker, S100, within nerve grafts using immunohistological methods and established the expression of ␤ 1 integrins, which are known to be involved in regeneration (13) .
In normal uninjured nerves, S100 immunoreactivity did not change significantly during the first 3 wk of postnatal development. In nerve grafts from animals of all ages, the pattern and intensity of S100 immunostaining examined 7 days after surgery was similar and was not significantly different from normal. Since S100 is also found in fibroblasts (19), we also examined H&E and Hoechst 33245 (bisbenzimide) stained, 3-, 5-, and 21-day-old nerve graft preparations to determine Schwann cell presence using other morphological criteria. Numerous elliptical cells aligned along the longitudinal axis of the nerve grafts and corresponding to the areas of S100 immunostaining were found in all 3 types of nerve grafts (results not shown).
Since it has been previously shown that integrins play a role in motoneuron survival (19) as well as axon regeneration (13), we next examined the expression of the ␤ 1 integrin receptor in nerve grafts of different ages by immunohistochemistry. Three days after transplantation of nerve grafts from P3 animals, the intensity of staining for ␤ 1 was very high, and was only slightly less in grafts from P5 animals. In grafts from 21-day-old rats, ␤ 1 immunoreactivity was much less intense. However, 7 days after grafting, ␤ 1 immunoreactivity in P3 nerve grafts declined dramatically and was almost undetectable (Fig.  4A ). In addition, no ␤ 1 immunoreactivity was observed in either the distal or proximal host nerve stump immediately adjacent to the graft. The ␤ 1 immunoreactivity that was present was mainly located in the connective tissue on the outside of the graft. In contrast, 7 days after grafting either P5 or P21 nerve grafts, ␤ 1 immunoreactivity was significantly greater than that observed 3 days after grafting (Fig. 4B) . The level of ␤ 1 immunoreactivity in P5 and P21 nerve grafts 7 days after surgery appeared very similar. Interestingly, no regenerating axons, (ie neurofilament immunoreactivity), could be seen in grafts from P3 animals, where integrin staining had declined by 7 days after grafting, although axons could be found in grafts from 5-and 21-day-old rats, where integrin staining was high.
The Effect of Manipulating Integrin Binding on Motoneuron Survival and Axon Growth
The above results show that 7 days after grafting, the intensity of staining for ␤ 1 integrins decreases dramatically in nerve grafts from 3-day-old rats, but not in grafts from animals aged 5 days and older. Since axon regeneration and motoneuron survival is more successful in animals that receive the older nerve grafts, where ␤ 1 integrin staining did not decline, we tested the possibility that these integrins may influence the ability of nerve grafts to support axon regeneration and motoneuron survival. Integrin binding in P3 and P5 nerve grafts was pharmacologically manipulated and the effect on motoneuron survival and axon growth examined 7 days later.
The Effect of Blocking Integrin Binding on Motoneuron Survival and Axon Growth:
The survival and growth of motoneurons injured 3 days after birth was significantly greater in animals that received nerve grafts from animals aged 5 days and older than in those that received either no graft or a graft from a 3-day-old animal. In the next set of experiments, integrin binding in grafts from 5-dayold animals was blocked by treatment of the graft with either FR-1 or a ␤ 1 integrin function-blocking antibody.
Motoneuron survival was examined 7 days later and the results are shown in Table 3 .
In rats receiving a P5 nerve graft that had been treated with FR-1, only 31.6% (Ϯ1.4 SEM, n ϭ 8) of motoneurons survived compared to over 70% in rats that had received an untreated graft from a 5-day-old donor. There was no significant difference in motoneuron survival between rats that received a control, NaCl-treated P5 graft and those receiving an untreated P5 graft. Thus, FR-1 treatment of P5 nerve grafts abolished the motoneuron survival-promoting effects of these grafts.
Since FR-1 blocks a variety of ␤ 1 and non-␤ 1 integrins capable of recognizing RGD (arginine-glycine-aspartate) binding sites, in a separate group of rats, grafts from 5-day-old rats were treated with a specific function-blocking anti-␤ 1 antibody. The results shown in Table 3 show that only 38.4% (Ϯ1.8 SEM, n ϭ 7) of axotomized motoneurons survived in this group. This level of motoneuron survival was not statistically different from that observed in Following axotomy at 3 days, host rats were implanted with nerve grafts taken from 5-day-old donor animals. The nerve grafts were treated with implants containing the integrin blocker FR-1 or with a function-blocking antibody to ␤ 1 -integrins. In control animals the graft was treated with NaCl implants. Motoneuron survival was examined 7 days later by counting the number of Nissl-stained motoneurons within the sciatic motor pool in both the operated (Op) and control (Con) ventral horns. The table shows the mean number of motoneurons on both sides. As an index of motoneuron survival, the number of motoneurons on the operated side is also expressed as a percentage of that on the control. SEM ϭ standard error of the mean. Following axotomy at 3 days, nerve grafts from 3-day-old donor rats were implanted into cut end of the host nerve. The nerve grafts were treated with implants containing either NaCl or PMA. Motoneuron survival was examined 7 days later by counting the number of Nissl-stained motoneurons within the sciatic motor pool in the operated (Op) and control (Con) ventral horn. The table shows the mean number of motoneurons on each side and as an index of motoneuron survival, the number of motoneurons on the operated side is also expressed as a percentage of the control. PMA ϭ phorbol 12-myristate 13-acetate; SEM ϭ standard error of the mean.
animals that had undergone a P3 axotomy only (p ϭ 0.751) or those that had received an untreated P3 nerve graft (p ϭ 0.951).
We also examined whether the decrease in motoneuron survival observed in FR-1-treated P5 nerve grafts was reflected in poor axonal growth into these grafts. Axon growth was assessed 7 days after surgery by immunostaining for neurofilaments. The results showed that although axons had clearly grown through the untreated P5 nerve grafts, in the majority of FR-1-treated P5 grafts, almost no axons could be seen within the nerve graft.
The Effect of Upregulating Integrin Binding on Motoneuron Survival:
The survival and regeneration of axotomized motoneurons is poor in those animals that receive a nerve graft from a 3-day-old donor. Moreover, ␤ 1 immunoreactivity in P3 nerve grafts declines rapidly within 7 days of surgery. In the next part of this study, we tested the possibility that increasing integrin binding in P3 nerve grafts by treatment with PMA (16) could improve their ability to support axon growth and promote motoneuron survival. As can be seen in Table 4 , treatment of P3 grafts with PMA resulted in a dramatic increase in motoneuron survival assessed 7 days later. Motoneuron survival in animals receiving an untreated P3 nerve graft was only 38.3% (Ϯ1.0 SEM, n ϭ 7), but this rose to 70.2% (Ϯ2.3 SEM, n ϭ 6) in rats that had received a PMA-treated P3 graft. Moreover, although there was no evidence of axon growth in untreated P3 grafts 7 days after surgery (Fig. 5A) , numerous axons could be seen extending through the length of the graft and into the first 3 mm of the distal nerve stump in the PMAtreated P3 grafts (Fig. 5B) . Thus, the increase in motoneuron survival observed in those animals that received PMA-treated P3 nerve grafts was reflected in a greater number of regenerating axons in the nerve graft. Immunostaining for ␤ 1 and S-100 showed that both ␤ 1 and S-100 staining was moderately increased in PMA-treated P3 nerve grafts.
DISCUSSION
The results of this study show that axotomized motoneurons can be rescued from cell death if their axons are connected to a peripheral nerve graft taken from a donor rat aged 5 days or older, but not if the graft is taken from a 3-day-old animal. Moreover, few axons regenerate into nerve grafts taken from 3-day-old donor animals, although extensive growth of axons was seen when the A section of a PMA-treated P3 nerve graft, 7 days after grafting. There is extensive axonal growth through the graft, with some axons extending into the distal host nerve stump. The arrows denote the proximal and distal graft anastomoses. Scale bar ϭ 1 mm grafts were taken from animals aged 5 days and older. Throughout these experiments we observed no evidence of graft rejection, irrespective of the age of the donor. We found no significant infiltration by inflammatory cells, as assessed by H&E staining.
These results are consistent with previous observations that indicate that adult nerve grafts are good conduits for axon regeneration (22, 23) , whereas axon growth through immature nerves is relatively poor (10) . The present results show that the change in the ability of nerve grafts to support axonal regeneration occurs between 3 and 5 days of age, a critical period of postnatal development. Although immunostaining for neurofilaments may not detect all regenerating axons, the results of this study also show that there is a good correlation between the extent of axon regeneration and motoneuron survival. Thus, in the group that received grafts from animals aged at least 5 days, significantly more motoneurons survived axotomy than in the group of animals that had received nerve grafts from 3-day-old donors or had an axotomy only. It is interesting to note that the switch in the ability of nerve grafts to promote motoneuron survival, which occurs between 3 and 5 days of age, coincides with the period during which motoneurons normally become independent of target contact and are able to survive following nerve injury (7, 8) . Although the vast majority of motoneurons innervating the soleus muscle die following nerve injury at birth, 20% of soleus motoneurons survive following injury at P3, and by P5 the same injury results in little or no motoneuron loss (7, 8) . Interestingly, injury in a 4-day-old rat results in an intermediate level of motoneuron survival and 43% of soleus motoneurons survive (24) . These findings indicate that there is a change in the peripheral nerve environment that occurs during postnatal development that is important for the maturation of motoneurons. Additionally, in the present experiments there is also a dramatic change in the ability of nerve grafts from rats aged 3 days to support motoneuron survival compared to grafts from 5-day-old rats. Taken together, these results show that the environment that damaged axons encounter following nerve injury can directly influence the survival of motoneurons and the regrowth of their axons.
RESCUE OF AXOTOMIZED MOTONEURONS BY NERVE GRAFTS
J Neuropathol Exp Neurol, Vol 62, January, 2003 that the precipitous loss of motoneurons that occurs within the first few days of neonatal injury can be reduced if a more favorable environment is provided to the cut end of their axons.
Previous results also show that altering the environment that growth cones encounter following axotomy can have a direct effect on motoneuron survival. Applying various trophic substances such as GDNF to the cut end of the sciatic nerve can increase motoneuron survival (27, 28) , most likely by activating a cascade of second messenger systems. It is possible that similar second messenger systems may be activated when regenerating growth cones interact with the ECM and Schwann cells within the more mature nerve grafts, but not within very immature neonatal grafts. The difference in the environment offered by a cut peripheral nerve from a neonatal and a more mature animal is not entirely clear. Although, following neonatal nerve injury there may be some loss of Schwann cells, the low level of reported Schwann cell death (29, 30 ) is unlikely to account for the inability of neonatal nerves to support motoneuron survival. It is possible that neonatal grafts may have reduced levels of trophic factors such as GDNF, although there is little evidence to suggest that neonatal Schwann cells lack GDNF (11) . Nevertheless, Schwann cells from axotomized neonatal nerves do not express the laminin/collagen receptor ␣1␤1 integrin, which is upregulated in Schwann cells following nerve injury in adults (16) . The ␣1␤1 integrin has been shown to play a role in nerve regeneration and may be involved in cell-cell contact between regenerating neurons and Schwann cells (12, 13, 16, 31) . Axon regeneration involves the interaction of growth cones with the ECM. Certain components of the ECM such as laminin and fibronectin have been shown to promote regeneration, and in nerves, integrins are the major ECM receptors. The primary receptor for fibronectin, ␣5␤1, has been shown to be present in nerve growth cones and Schwann cells in vivo (32) . Our present results in vivo show that ␤1 integrins, although present at high levels in normal neonatal nerves, decline rapidly after axotomy, but increase dramatically in the more mature axotomized nerves. These findings are similar to previous observations that show that nerve section in the adult results in an increase in ␤1 mRNA levels in motoneurons, although the same injury in neonates results in very little change (17) . The possible role of ␤1 integrins in the survival of injured motoneurons is supported by the present results that show that blocking ␤1 integrin binding in the older nerve grafts dramatically reduces the ability of these grafts to promote motoneuron survival. Moreover, treatment of neonatal nerve grafts with a phorbol ester, which activates protein kinase C and has been shown to result in an upregulation in ␤1 integrin levels in cultured Schwann cells (16) , results in a dramatic improvement in motoneuron survival. However, it is possible that by activating PKC, PMA may act on multiple signaling systems.
There are several molecules that are able to rescue axotomized motoneurons from cell death. Various trophic factors have been shown to promote motoneuron survival (27, 33, 34) , and in all cases these factors also increase the activity of ACh-synthesizing enzyme, choline acetyltransferase (ChAT). Moreover, treatment of nerve terminals or growth cones with brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) also results in increased ACh release, although the mechanism by which this is achieved is unclear (35) (36) (37) . Interestingly, there is now evidence that shows that integrins play an important role in the regulation of transmitter release from nerve terminals (38, 39) . These authors suggest that integrins at the neuromuscular junction can act as mechanotransducers, so that tension on integrins in the presynaptic membrane is transmitted as mechanical signals to other regions of the cell, resulting in an increased probability of vesicle docking and fusion. Active zones on motor nerve terminals have also been shown to contain ␤1 integrins, where they are thought to play a role in adhesion of the nerve terminal to the synaptic basal lamina, as well as in exocytosis of neurotransmitter (40) . Furthermore, we have previously demonstrated the importance of integrin signaling in motoneuron survival in experiments in which integrin binding at the neuromuscular junction in neonatal rats was blocked, resulting not only in motoneuron death, but also a decrease in ChAT activity, indicating a reduction in ACh synthesis and release (19) .
Thus, a wide variety of apparently unrelated molecules seem to be able to rescue axotomized neonatal motoneurons from cell death. These range from neurotrophic factors such as GDNF (28) , TGF-beta (41), potassium channel blockers (42) , to the present findings that demonstrate the survival-promoting effects of the phorbol ester, PMA. However, it is possible that this wide range of molecules mediate their effects through similar signaling pathways. During regeneration, integrins either on the growth cone or the Schwann cells, may interact with complementary ligands or mediate intracellular signals that may be involved in not only promoting axon growth but also preventing apoptosis. Integrins have been shown to activate the phosphoinositide 3-OH kinase B/Akt pathway in vitro, and activation of this pathway has been found to protect axotomized hypoglossal motoneurons in vivo (43) . Furthermore, these authors argue that this pathway plays dual roles in both motoneuron survival and nerve regeneration (44) .
The results of this study therefore show that mature nerves are better conduits for axon regeneration than neonatal nerves. Furthermore, the improvement in regeneration observed in nerve grafts from animals of at least 5 days of age is accompanied by a dramatic increase in motoneuron survival. In order to demonstrate that those motoneurons rescued by the older grafts were in fact functional, it would be necessary to carry out physiological studies on the target muscles. However, in the present experiments it was not possible to carry out such studies since at the time that motoneuron survival was assessed, at 7 days postimplantation, regenerating axons had not yet reached the target muscle and had only extended to a maximum of 5 mm into the distal host nerve stump. Therefore, physiological recordings of muscle fibers were not possible.
In support of the present findings are recent results that show that following spinal root section, immature motoneurons are unable to regenerate their axons into peripheral nerve grafts inserted into the spinal cord, although motoneurons in more mature animals were able to regenerate (45) . However, these authors suggest that the regenerative capacity of motoneurons begins only at P14. However, our present results show that even immature motoneurons can regenerate and survive given an appropriate environment for axonal growth. Thus, the environment that growth cones encounter as the axons regenerate plays an important role in determining motoneuron survival even prior to target reinnervation. These results reflect the findings that nerve injury in animals aged 5 days and older results in minimal motoneuron death, although the same injury in neonatal and 3-dayold rats results in a significant loss of motoneurons (6) . The results of the present study also illustrate that integrins play an important role in regeneration and confirm our previous findings (19) that indicate that integrins may be directly or indirectly involved in promoting motoneuron survival. Furthermore, treatment with PMA induces a change in the neonatal nerve environment so that it is able not only to support axon growth but also rescue target-deprived motoneurons from cell death. However, the precise mechanism of action of integrins and PMA remain to be established.
